A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

HYDROmorphone HCl Extended-Release Tablets 8 mg; 12 mg; 16 mg; 32 mg

Please see Boxed WARNING and safety information in accompanying prescribing information.

Risk Evaluation and Mitigation Strategies | REMS | FDA

NDC	Size	Case
0574-0293-01	100 Tablets	12
0574-0294-01	100 Tablets	12
0574-0295-01	100 Tablets	12
0574-0297-01	100 Tablets	12

Product Catalog Disclaimer

The product information presented here is intended for use by industry professionals, health-care professionals, patients and consumers in the United States only. Countries outside the U.S. may have different regulatory requirements and review practices that may require the use and availability of different information. Perrigo and its affiliates can take no responsibility for the reliance on or use of any information contained herein (see our Legal Disclaimer).

HYDROmorphone HCl Extended-Release Tablets 8 mg; 12 mg; 16 mg; 32 mg

Product Catalog Disclaimer

© Padagis®. All Rights Reserved.

Patent Resources

Terms and Conditions

Privacy Statement